Cargando…
Perspectives on the Role of Endocannabinoids in Autism Spectrum Disorders
Autism spectrum disorders (ASDs) are diagnosed on the basis of three behavioral features, namely, (1) deficits in social communication, (2) absence or delay in language and (3) stereotypy. The consensus regarding the neurological pathogenesis of ASDs is aberrant synaptogenesis and synapse function....
Autores principales: | Yeh, Mason L., Levine, Eric S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407886/ https://www.ncbi.nlm.nih.gov/pubmed/30854511 http://dx.doi.org/10.21926/obm.neurobiol.1702005 |
Ejemplares similares
-
Lower circulating endocannabinoid levels in children with autism spectrum disorder
por: Aran, Adi, et al.
Publicado: (2019) -
The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models
por: Zamberletti, Erica, et al.
Publicado: (2017) -
Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder
por: Zou, Mingyang, et al.
Publicado: (2021) -
The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders
por: Coccurello, Roberto, et al.
Publicado: (2022) -
Role for Endogenous BDNF in Endocannabinoid-Mediated Long-Term Depression at Neocortical Inhibitory Synapses1,2,3
por: Zhao, Liangfang, et al.
Publicado: (2015)